MOREPEN LABORATORIES
Back to Balance Sheet
|
MOREPEN LABORATORIES Last 5 Year Total Non-Current Liabilities History
[Consolidated]
Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
---|---|---|---|---|---|
Total Non-Current Liabilities | ₹90 Cr | ₹44 Cr | ₹37 Cr | ₹35 Cr | ₹30 Cr |
What is the latest Total Non-Current Liabilities ratio of MOREPEN LABORATORIES ?
Year | Total Non-Current Liabilities |
---|---|
Mar2025 | ₹90 Cr |
Mar2024 | ₹44 Cr |
Mar2023 | ₹37 Cr |
Mar2022 | ₹35 Cr |
Mar2021 | ₹30 Cr |
How is Total Non-Current Liabilities of MOREPEN LABORATORIES Trending?
Years | Total Non-Current Liabilities | % Change | |
---|---|---|---|
Mar2025 | ₹90 Cr | 105.96 | |
Mar2024 | ₹44 Cr | 19.11 | |
Mar2023 | ₹37 Cr | 3.91 | |
Mar2022 | ₹35 Cr | 18.10 | |
Mar2021 | ₹30 Cr | - |
Compare Total Non-Current Liabilities of peers of MOREPEN LABORATORIES
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
MOREPEN LABORATORIES | ₹2,702.2 Cr | 2.4% | -12.8% | -39.7% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹382,622.0 Cr | 2% | -2.3% | -12.6% | Stock Analytics | |
DIVIS LABORATORIES | ₹159,536.0 Cr | -1.3% | -6.2% | 21.2% | Stock Analytics | |
CIPLA | ₹125,468.0 Cr | -2.2% | 3.6% | -4.5% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹121,162.0 Cr | -0% | -0.3% | 5% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹105,874.0 Cr | -0.9% | 4.5% | -8.6% | Stock Analytics |
MOREPEN LABORATORIES Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
MOREPEN LABORATORIES | 2.4% |
-12.8% |
-39.7% |
SENSEX | 1.1% |
-0.4% |
-2.2% |
You may also like the below Video Courses